Why Nicardipine may not be a good option for hypertensive patient with respiratory distress

Clinical Scenario:

Hypertensive patient brought in by ambulance for hypertensive urgency. She’s been coughing x 2 days with a recent diagnosis for pneumonia. BP 198/120, HR 130’s, 10L 02 with a saturation of 92%.

Hypoxia affects people with lung problems like pneumonia, edema, or atelectasis even more. These issues put extra stress on the lungs, making hypoxia worse. In pneumonia, hypoxic pulmonary vasoconstriction (HPV) is an important way our body tries to keep things in check. Basically, when there’s low oxygen in the air sacs (due to infection or fluid), the small blood vessels in the lungs tighten up. This clever move helps steer blood away from the parts of the lungs that aren’t doing so well and into the areas that are getting enough air, which helps fix the ventilation/perfusion (V̇/Q̇) mismatch.

[ Ventilation-Perfusion Mismatch. When the airflow in your lungs doesn’t line up with the blood flow, you’ll see it in the V/Q ratio, which basically tells us how well gas is getting traded out in the lungs. If there isn’t enough air getting in, that V/Q ratio takes a hit, which means your body isn’t getting enough oxygen, and it also struggles to get rid of carbon dioxide effectively ]

Pathophysiology

Nicardipine’s role: Nicardipine works by blocking calcium from getting into the smooth muscles of blood vessels, which stops them from tightening up, even when there’s not much oxygen around.

Nicardipine, a calcium channel blocker, has the potential to induce pulmonary shunting by inhibiting hypoxic pulmonary vasoconstriction (HPV), a physiological reflex of the lungs that directs blood away from areas with insufficient oxygenation. This alteration in blood flow results in the perfusion of “dead” lung segments (shunt), exacerbating hypoxemia, particularly in individuals with pre-existing pulmonary conditions such as pneumonia or pulmonary edema; however, this effect is frequently reversible upon discontinuation of the medication. While clinically significant shunting associated with nicardipine is infrequent, it necessitates vigilant monitoring of oxygen saturation and blood pressure.

Names, dates, and personal identifying details have been changed throughout this website to comply with the Health Insurance Portability and Accountability Act (HIPAA). **